18 Sep 2023 --- The human milk oligosaccharide (HMO) science team at Chr. Hansen reveals the results of a comprehensive review of 26 clinical studies, which it says provides compelling evidence on the safety, toleration and positive effects of HMO supplementation during infancy, early childhood and beyond.
